Efficacy and safety of Xian-Lian-Jie-Du optimization decoction as an adjuvant treatment for prevention of recurrence in patients with stage IIIB/IIIC colon cancer: study protocol for a multicentre, randomized controlled trial

被引：0

作者：

Xuechen Geng

Ziqiang Wang

Li Feng

Yanhong Gu

Renjie Wang

Qinghua Yao

Yangxian Xu

Jianyu Wu

Zhiwei Jiang

Kai Chen

Wenwei Hu

Dongxin Tang

Jiege Huo

Ling Li

Qianqian Bu

Shuoqi Zhao

Bei Zhang

Haibo Cheng

机构：

[1] Nanjing University of Chinese Medicine,The First Clinical Medical College, Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor

[2] Colorectal Cancer Center,Department of General Surgery

[3] West China Hospital,Traditional Chinese Medicine Department

[4] Sichuan University,Department of Oncology and Cancer Rehabilitation Centre

[5] National Cancer Center/Cancer Hospital,Department of Colorectal Surgery

[6] Chinese Academy of Medical Science and Peking Union Medical College,Department of Integrated Chinese and Western Medicine, Institute of Basic Medicine and Cancer (IBMC)

[7] The First Affiliated Hospital of Nanjing Medical University,Department of General Surgery

[8] Fudan University Shanghai Cancer Center,No. 2 Surgery Department

[9] The Cancer HospitalUniversity of Chinese Academy of Sciences (Zhejiang Cancer Hospital)Chinese Academy of Sciences,Department of General Surgery

[10] Longhua Hospital,Department of Oncology

[11] Shanghai University of Traditional Chinese Medicine,Department of Oncology

[12] The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine,Clinical Medical Research Center

[13] The Affiliated Hospital of Nanjing University of Chinese Medicine,Affiliated Hospital of Integrated Traditional Chinese and Western Medicine

[14] Jiangsu Province Hospital of Chinese Medicine,Chinese Evidence

[15] The First Affiliated Hospital of Soochow University,Based Medicine Center, NMPA Key Laboratory for Real World Data Research and Evaluation in Hainan, Sichuan Center of Technology Innovation for Real World Data

[16] The Third Affiliated Hospital of Soochow University,Department of TCM

[17] The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine,undefined

[18] Nanjing University of Chinese Medicine,undefined

[19] Jiangsu Province Academy of Traditional Chinese Medicine,undefined

[20] West China Hospital,undefined

[21] Sichuan University,undefined

[22] State Key Laboratory of Oncology in South China,undefined

[23] Sun Yat-Sen University Cancer Center,undefined

[24] Collaborative Innovation Center of Cancer Medicine,undefined

[25] Sun Yat-Sen University Cancer Center,undefined

来源：

BMC Complementary Medicine and Therapies | / 23卷

关键词：

Xian-Lian-Jie-Du optimization decoction; Colon cancer; Chinese herbal medicine; Randomized controlled trial; Protocol;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 20 条

[1] Efficacy and safety of Xian-Lian-Jie-Du optimization decoction as an adjuvant treatment for prevention of recurrence in patients with stage IIIB/IIIC colon cancer: study protocol for a multicentre, randomized controlled trial
Geng, Xuechen
Wang, Ziqiang
Feng, Li
Gu, Yanhong
Wang, Renjie
Yao, Qinghua
Xu, Yangxian
Wu, Jianyu
Jiang, Zhiwei
Chen, Kai
Hu, Wenwei
Tang, Dongxin
Huo, Jiege
Li, Ling
Bu, Qianqian
Zhao, Shuoqi
Zhang, Bei
Cheng, Haibo
[J]. BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2023, 23 (01)
[2] The efficacy and safety of a Huanglian-jie-du decoction on Hwa-byung patients: A study protocol for a randomized controlled trial
Choi, Yu-Jin
Chung, Sun-Yong
Cho, Seung-Hun
[J]. JOURNAL OF PHARMACOPUNCTURE, 2018, 21 (01) : 7 - 13
[3] Efficacy and safety of Shenmayizhi decoction as an adjuvant treatment for vascular dementia Study protocol for a randomized controlled trial
Wang, Huichan
Liu, Nanyang
Wei, Yun
Pei, Hui
Liu, Meixia
Diao, XueMei
Zhang, Huiqin
Li, Hao
[J]. MEDICINE, 2019, 98 (50)
[4] Study protocol of the SACURA trial: a randomized phase III trial of efficacy and safety of UFT as adjuvant chemotherapy for stage II colon cancer
Megumi Ishiguro
Hidetaka Mochizuki
Naohiro Tomita
Yasuhiro Shimada
Keiichi Takahashi
Kenjiro Kotake
Masahiko Watanabe
Yukihide Kanemitsu
Hideki Ueno
Toshiaki Ishikawa
Hiroyuki Uetake
Shigeyuki Matsui
Satoshi Teramukai
Kenichi Sugihara
[J]. BMC Cancer, 12
[5] Study protocol of the SACURA trial: a randomized phase III trial of efficacy and safety of UFT as adjuvant chemotherapy for stage II colon cancer
Ishiguro, Megumi
Mochizuki, Hidetaka
Tomita, Naohiro
Shimada, Yasuhiro
Takahashi, Keiichi
Kotake, Kenjiro
Watanabe, Masahiko
Kanemitsu, Yukihide
Ueno, Hideki
Ishikawa, Toshiaki
Uetake, Hiroyuki
Matsui, Shigeyuki
Teramukai, Satoshi
Sugihara, Kenichi
[J]. BMC CANCER, 2012, 12
[6] Efficacy and safety of Shengjiang Xiexin decoction in prophylaxis of chemotherapy-related diarrhea in small cell lung cancer patients: study protocol for a multicenter randomized controlled trial
Chao Deng
Yanni Lou
Yu Gao
Bo Deng
Fei Su
Liqun Jia
[J]. Trials, 21
[7] Efficacy and safety of Shengjiang Xiexin decoction in prophylaxis of chemotherapy-related diarrhea in small cell lung cancer patients: study protocol for a multicenter randomized controlled trial
Deng, Chao
Lou, Yanni
Gao, Yu
Deng, Bo
Su, Fei
Jia, Liqun
[J]. TRIALS, 2020, 21 (01)
[8] mFOLFIRINOX versus mFOLFOX 6 as adjuvant treatment for high-risk stage III colon cancer - the FROST trial: study protocol for a multicenter, randomized controlled, phase II trial
Kyung-Ha Lee
In Jun Yang
Gi Won Ha
Jaeim Lee
Youn Young Park
Suk Hwan Lee
Jong Min Lee
Jung Hoon Bae
Eun Jung Park
Hyungjin Kim
Keun Young Kim
Sanghyung An
Ik Yong Kim
Ji Yeon Kim
[J]. BMC Cancer, 24
[9] mFOLFIRINOX versus mFOLFOX 6 as adjuvant treatment for high-risk stage III colon cancer - the FROST trial: study protocol for a multicenter, randomized controlled, phase II trial
Lee, Kyung-Ha
Yang, In Jun
Ha, Gi Won
Lee, Jaeim
Park, Youn Young
Lee, Suk Hwan
Lee, Jong Min
Bae, Jung Hoon
Park, Eun Jung
Kim, Hyungjin
Kim, Keun Young
An, Sanghyung
Kim, Ik Yong
Kim, Ji Yeon
[J]. BMC CANCER, 2024, 24 (01)
[10] Efficacy of Hwangryunhaedok-tang (Huang-lian-jie-du-tang, Oren-gedoku-to) for patients with hyperlipidemia: a study protocol for a randomized, double-blind, placebo-controlled, parallel, investigator-initiated clinical trial
Lee, Boram
Han, Kyungsun
Park, Hyo-Ju
Kim, Ae-Ran
Kwon, O-Jin
Yang, Changsop
Cho, Chung-Sik
[J]. TRIALS, 2020, 21 (01)

← 1 2 →